Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

New Jersey joined 22 states suing the Trump administration to stop its plan to cut more than $11 billion in funding for ...

South Australian families will now have better protection against a potentially deadly respiratory virus, under a free state ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...

If you haven’t gotten the flu shot, now may be the time. A record number of influenza cases has been reported in Australia, while Covid-19 and other respiratory illnesses are also circulating widely.

Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...

For the first time, RSV immunisation is now available to Western Australians both during pregnancy, and for eligible babies ...

Read about what public health experts from nursing backgrounds think should be done to address dwindling childhood ...